ALK and non-small cell lung carcinoma: Perhaps the most widely recognized is the echinoderm microtubule-associated protein-like 4 (EML4)-ALK fusion, identified in 5–6% of non-small-cell lung cancer (NSCLC) patients in 2007 [7].